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During limb skeletogenesis the cartilaginous long bone anlagen and their growth plates become
delimited by perichondrium with which they interact functionally. Yet, little is known about how,
despite being so intimately associated with cartilage, perichondrium acquires and maintains its distinct
phenotype and exerts its border function. Because perichondrium becomes deranged and interrupted
by cartilaginous outgrowths in Hereditary Multiple Exostoses (HME), a pediatric disorder caused by EXT
mutations and consequent heparan sulfate (HS) deﬁciency, we asked whether EXT genes and HS
normally have roles in establishing its phenotype and function. Indeed, conditional Ext1 ablation in
perichondrium and lateral chondrocytes ﬂanking the epiphyseal region of mouse embryo long bone
anlagen – a region encompassing the groove of Ranvier – caused ectopic cartilage formation. A similar
response was observed when HS function was disrupted in long bone anlagen explants by genetic,
pharmacological or enzymatic means, a response preceded by ectopic BMP signaling within perichon-
drium. These treatments also triggered excess chondrogenesis and cartilage nodule formation and
overexpression of chondrogenic and matrix genes in limb bud mesenchymal cells in micromass culture.
Interestingly, the treatments disrupted the peripheral deﬁnition and border of the cartilage nodules in
such a way that many nodules overgrew and fused with each other into large amorphous cartilaginous
masses. Interference with HS function reduced the physical association and interactions of BMP2 with
HS and increased the cell responsiveness to endogenous and exogenous BMP proteins. In sum, Ext genes
and HS are needed to establish and maintain perichondrium’s phenotype and border function, restrain
pro-chondrogenic signaling proteins including BMPs, and restrict chondrogenesis. Alterations in these
mechanisms may contribute to exostosis formation in HME, particularly at the expense of regions rich
in progenitor cells including the groove of Ranvier.
& 2013 Elsevier Inc. All rights reserved.Introduction
Long bones begin to form at mid stages of embryogenesis in
many vertebrate species, including mice and chicks (Hinchliffe
and Johnson, 1980; Ota and Kuratani, 2009). Onset of their
development becomes apparent with the formation of uninter-
rupted Y-shaped preskeletal mesenchymal condensations that
correspond to the proximal stylopod elements (humerus andll rights reserved.
902, Philadelphia, PA 19104,
el08@gmail.com (J. Huegel).femur) and medial zeugopod elements (radius/ulna and tibia/
ﬁbula). Soon after, the condensed cells differentiate into chon-
drocytes that produce cartilage matrix, establish the cartilaginous
skeletal primordia and become organized into growth plates
(Kronenberg, 2003). The cells adjacent to the cartilaginous ele-
ments remain mesenchymal, forming the perichondrium that
surrounds the elements all along their longitudinal length as well
as at their epiphyseal ends where the synovial joints begin to
form (Eames et al., 2003; Hall and Miyake, 2000; Holder, 1977).
The mesenchymal cells located at those joint sites and now
interrupting the elements at the prospective elbow and knee
joints are collectively called the interzone (Paciﬁci et al., 2005).
While initially loose and non-descript, the perichondrial cells
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rise to the distinct layers of perichondrium. Speciﬁcally, the inner
layer becomes composed of cuboidal progenitor cells and the outer
layer contains elongated ﬁbrogenic and mechanically-endowed cells
(Bairati et al., 1996; Bandyopadhyay et al., 2008; Gigante et al.,
1996; Scott-Savage and Hall, 1980). Starting in diaphysis, the growth
plate chondrocytes undergo maturation and hypertrophy and pro-
duce the signaling protein Indian hedgehog (Ihh) that diffuses into
the adjacent perichondrium and induces formation of the intra-
membranous bone collar (Koyama et al., 1996a; Vortkamp et al.,
1996). This elicits a local transition from perichondrium to perios-
teum characterized by marked changes in cell phenotype and gene
expression (Koyama et al., 1996b). Ihh is also part of another
regulatory loop with periarticular cells that produce parathyroid
hormone-related protein (PTHrP) and regulate the overall rates of
chondrocyte maturation in the growth plate (Vortkamp et al., 1996).
In addition, several members of the bone morphogenetic protein
(BMP) and ﬁbroblast growth factor (FGF) families are expressed in
growth plate and/or perichondrium and have been shown to be part
of interactive loops regulating Ihh and PTHrP expression and overall
growth plate activities (Pathi et al., 1999; Zou et al., 1997). These
and several other studies have provided compelling evidence that
the growth plate and perichondrium are engaged in multiple
interactions critical for skeletal development and growth (Alvarez
et al., 2001, 2002; Colnot et al., 2004; Long and Linsenmayer, 1998).
However, what has remained less understood is how, though
adjacent and so intimately interconnected to cartilage, perichon-
drium is actually able to acquire and maintain its phenotype and
exert its boundary functions.
Heparan sulfate (HS) constitutes the glycosaminoglycan moiety
of cell surface and matrix proteoglycans that include syndecans,
glypicans and perlecan (Bernﬁeld et al., 1999). The HS chains are
composed of repeating D-glucuronic acid (GlcA) and N-acetyl-D-
glucosamine (GlcNAc) residues that are assembled into linear
polysaccharides by the Golgi-associated heterodimer of Ext1 and
Ext2 glycosyltransferases (Esko and Selleck, 2002). During assembly,
the nascent chains undergo extensive modiﬁcations that include
N-deacetylation/N-sulfation, epimerization, and O-sulfation. These
multiple and systematic reactions result in the creation of patterns
of speciﬁc negatively-charged sulfated segments of modiﬁed sugars
within the chains of HS-proteoglycans expressed in different tissues
and organs (Bulow and Hobert, 2006). Thus endowed, the resultant
heparan sulfate proteoglycans can inﬂuence cell determination and
differentiation, cell-matrix interactions, and cell-growth factor inter-
actions (Bishop et al., 2007; Hacker et al., 2005). Cell-growth factor
interactions are of particular relevance since several signaling
proteins and growth factors critical for skeletogenesis including
BMPs, FGFs and hedgehog family members, are HS-binding factors
(Bernﬁeld et al., 1999; Lin, 2004). Previously we and other groups
showed that deﬁciency in Ext1 and/or Ext2 expression alters the
organization and functioning of the growth plate and can lead to
growth aberrations (Hilton et al., 2005; Koziel et al., 2004; Stickens
et al., 2005; Zak et al., 2011). Growth plate and skeletal aberrations
were also observed in mutant mice of HS modifying genes such as 6-
O-sulfotransferase-1 and N-sulfotransferase 1. Ablation of Perlecan or
Glypican-3 genes, both of which encode HSPG core proteins and are
expressed in the growth plate, also results in growth plate and
skeletal abnormalities (Arikawa-Hirasawa et al., 1999; Habuchi
et al., 2007; Viviano et al., 2005; Yasuda et al., 2010). These
observations suggest that HS-dependent mechanisms are major
regulators of skeletogenesis and growth plate function, but far less
is known about whether similar mechanisms operate in perichon-
drium to regulate its phenotype and roles.
Hereditary multiple exostoses (HME; also called Multiple Osteo-
chondroma or Multiple Hereditary Exostoses) is a congenital
pediatric skeletal disorder caused by heterozygous loss-of-functionmutations in EXT1 or EXT2 and consequent HS deﬁciency (Ahn et al.,
1995; Lind et al., 1998). HME is characterized by cartilaginous and
bony outgrowths (exostoses) that form next to, but never within, the
growth plates. Given their location, the exostoses interrupt the
continuity of the perichondrium, violate the chondro-perichondrial
border and protrude into surrounding tissues causing multiple
complications, and it has been suggested that they arise from
perichondrial cells (Hecht et al., 2005; Porter and Simpson, 1999).
Thus, we reasoned that Ext genes and HS could normally be part of
mechanisms by which the perichondrium acquires and maintains
its ﬁbrogenic phenotype and exerts its boundary roles along
the chondro-perichondrial border. The genetic, pharmacologic and
biochemical-biophysical data we report here do support such a
possibility.Materials and methods
Mouse lines, mating and genotyping
Gdf-5-Cre transgenic mice were described previously (Rountree
et al., 2004) and line B was used in the present study. Creation of
loxP-modiﬁed Ext1 allele and establishment of the Ext1 ﬂoxed mouse
line (Ext1ﬂox/ﬂox) were described previously (Inatani et al., 2003).
eYFP mice were obtained from Jackson labs (stock number 006148).
Pregnant mice and postnatal mice were sacriﬁced by IACUC
approved methods. Genotyping was carried out with DNA isolated
from tail clips.
In situ hybridization and proliferation analysis
In situ hybridization was carried out as described (Koyama et al.,
1999). Limbs ﬁxed with 4% paraformaldehyde overnight were
embedded in parafﬁn and sectioned. Serial 5-mm-thick sections
from wild type and mutants mounted on the same slide were
pretreated with 10 mg/ml proteinase K (Sigma, St. Louis, MO) in
50 mM Tris–HCl, 5 mM EDTA pH 7.5 for 1 min at room temperature,
immediately post-ﬁxed in 4% paraformaldehyde buffer for 10 min,
and then washed twice in 1 PBS containing 2 mg/ml glycine for
10 min/wash. Sections were treated for 15 min with a freshly
prepared solution of 0.25% acetic anhydride in triethanolamine
buffer and were hybridized with antisense or sense 35S-labeled
riboprobes (approximately 1106 DPM/section) at 50 1C for 16 h.
cDNA clones used as templates for probes included: a 121 bp mouse
collagen IIA (284–404, NM_008109); a 356 bp mouse collagen IIB
(2409–2764, NM_008109); a 254 bp mouse histone 4C (H4C) (546–
799; AY158963); a 515 bp mouse collagen X (1302–1816); a 741 bp
mouse Sox9 (116–856; NM_011448) and a 591 bp mouse Tenascin-
C (544–1124, NM_011607.3). After hybridization, slides were
washed three times with 2 SSC containing 50% formamide at
50 1C for 20 min/wash, treated with 20 mg/ml RNase A for 30 min at
37 1C, and washed three times with 0.1 SSC at 50 1C for 10 min/
wash. Sections were dehydrated by immersion in 70, 90, and 100%
ethanol for 5 min/step, coated with Kodak NTB-3 emulsion diluted
1:1 with water, and exposed for 10–14 days. Slides were developed
with Kodak D-19 at 20 1C for 3 min, and stained with hematoxylin
and eosin. Bright and dark-ﬁeld images of in situ hybridization were
taken with a SPOT insight camera (Diagnostic Instruments, Inc.)
operated with SPOT 4.0 software. No further processing of images
was performed apart from assembling montages in Photoshop
(version 8, Adobe).
Explant cultures
Forelimb elements were isolated from P1 Ext1ﬂox/ﬂox neonates
and cultured on ﬁlter membranes in DMEM supplemented with
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at a concentration of 109 virus particles per ml of media. Control
samples were treated with Ad-CMV-GFP (Vector Biolabs) at the
same concentration. Samples were incubated for 6 days. Similar
experiments were performed using P1 WT forelimbs with the
addition of 10 mM Surfen (Drug Synthesis and Chemistry Branch,
Division of Cancer Treatment and Diagnosis, National Cancer
Institute, Bethesda, MD).
Immunohistochemistry
Immunostaining for phospho-Smad1/5/8 was carried out with
parafﬁn sections that were ﬁrst deparafﬁnized and then treated
with 1 mg/ml pepsin for 10 min at 37 1C to de-mask the tissue.
Sections were incubated with anti-phospho-Smad1/5/8 polyclo-
nal antibody (Cell Signaling 9511) at 1:200 dilution in 3% NGS in
PBS overnight at 4 1C. Following rinsing, sections were then
incubated with biotinylated anti-rabbit secondary antibody and
the signal was visualized using a HRP/DAB detection IHC kit
according to the manufacturer’s instructions (Abcam). Bright-ﬁeld
images were taken with a SPOT insight camera (Diagnostic
Instruments, Inc.) operated with SPOT 4.0 software.
Preparation, treatment and analysis of micromass cultures
Micromass cultures were prepared from the mesenchymal
cells of E11.5 mouse embryo limb buds (Ahrens et al., 1979).
Dissociated cells were suspended at a concentration of
5106 cells/ml in DMEM containing 3% fetal bovine serum and
antibiotics. Micromass cultures were initiated by spotting 20 ml of
the cell suspensions (1.5105 cells) onto the surface of 12-well
tissue culture dishes. After a 90-minute incubation at 37 1C in a
humidiﬁed CO2 incubator to allow for cell attachment, the
cultures were supplied with 0.25 ml of medium. After 24 h,
medium supplemented with the indicated concentrations of
Surfen, heparitinase III (Sigma), recombinant human BMP2 (R&D
Systems), recombinant mouse Noggin (R&D Systems), or combi-
nations of Surfen/rhBMP2 or Surfen/Noggin were added to the
cultures. Fresh reagents (drug and/or protein) were given with
medium change every other day. Equivalent amounts of vehicle
were added to control cultures. Cultures were stained with Alcian
blue (pH 1.0) after 5 days to monitor chondrogenic cell differ-
entiation. Micromass analysis was performed using ImageJ.
Images were made binary under an RGB threshold, and ‘‘Particle
Analysis’’ was utilized to measure nodule size, number, and Alcian
blue positive area.
Timed matings were used to collect E11.5 Ext1ﬂox/ﬂox embryo-
nic limb buds for micromass cultures. Cells were plated using the
above procedure with the addition of adeno-CMV-Cre (Vector
Biolabs, MOI 1000) after cell attachment.
Semiquantitative and real time PCR analyses
Total RNA was extracted from cells by the guanidine phenol
method using TRIzol reagent (Invitrogen) according to the manufac-
turer’s protocols. One microgram of total RNA was reverse tran-
scribed using the SuperScript III First-Strand Synthesis System (Life
Technologies). Quantitative real-time PCR was conducted using SYBR
Green PCR Master Mix in an Applied Biosystems 7900HT according
to the manufacturer’s protocols. The housekeeping gene GAPDH was
used as an internal control for quantiﬁcation. The following primer
sets were used: Gapdh forward primer (50-CGTCCCGTAGAC-
AAAATGGT-30) and reverse primer (50-TTGATGGCAACAATCTCCAC-
30); Sox9 forward primer (50-GAGCTCAGCAAGACTCTGGG-30) and
reverse primer (50-CGGGGCTGGTACTTGTAATC-30); Runx2 for-
ward primer (50-CGCACGACAACCGCACCAT-30) and reverse primer50-AACTTCCTGTGCTCCGTGCTG-30); Agg forward primer (50-GGAGC-
GAGTCCAACTCTTCA-30) and reverse primer (50-CGCTCAGTGAGTTGT-
CATGG-30); Col2a1 forward primer (50-CTACGGTGTCAGGGCCAG-30)
and reverse primer (50-GTGTCACACACACAGATGCG-30); Col10a1 for-
ward primer (50-CATAAAGGGCCCACTTGCTA-30) and reverse primer
(50ACCAGGAATGCCTTGTTCTC-30). Band intensities for semiquantita-
tive PCR were normalized to GAPDH and compared while the band
intensities and cycle numbers are linear. The following primer sets
were used: BMP2 forward primer (50-TCTTCCGGGAACAGATACAGG-
30) and reverse primer (50-TCTCCTCTAAATGGGCCACTT-30); BMPRI
forward primer (50-GCTTGCGGCAAtCGTGTCTAA-30) and reverse
primer (50-GCAGCCTGTGAAGATGTAGAGG-30); BMPRII forward pri-
mer (50-CACACCAGCCTTATACTCTAGATA-30) and reverse primer
(50-CACATATCTGTTATGAAACTTGAG-30).Reporter assays
Mouse mesenchymal C3H10T1/2 cells were seeded in mono-
layer culture in a 96-well plate and serum-starved overnight.
Cultures were co-transfected with 100 ng per well of canonical
BMP signaling reporter Id1-Luc plasmid (Korchynsky and ten
Dijke, 2002) and 1 ng/well of phRG-TK (Promega) using 0.2 ml of
Lipofectamine LTX (Invitrogen) according to the manufacturer’s
protocol. After 6 h, media was replaced with medium supple-
mented by indicated concentrations of Surfen, rhBMP2, recombi-
nant mouse Noggin, or combinations of Surfen/BMP2 or Surfen/
Noggin. Control wells received equivalent amounts of vehicle
(0.1% BSA/PBS or DMSO). Twenty-four hours later, cells were
harvested and subjected to dual luciferase assay (Promega);
transfection efﬁciency was normalized to Renilla luciferase activ-
ity generated by phRG-TK.Protein analysis
C3H10T1/2 cells were grown to 70% conﬂuence in 6-well
plates and treated with indicated concentrations of rhBMP2 or
Surfen. Total cellular proteins harvested in SDS-PAGE sample
buffer were electrophoresed on 4–15% SDS-Bis-Tris gels (40 mg
per lane) and transferred to PVDF membranes (Invitrogen).
Membranes were incubated overnight at 4 1C with dilutions of
antibodies against phospho-Smad1/5/8 (Cell Signaling Technol-
ogy 9511, 1:1000) or Smad1 (Abcam 63439, 1:500). Enhanced
chemiluminescent immunoblotting detection system (Pierce) was
used to detect the antigen-antibody complexes. The membranes
were re-blotted with antibodies to a-tubulin (Sigma T-5168,
1:2000) for normalization, and band intensities were quantiﬁed
by computer-assisted image analysis.Surface plasmon resonance (SPR) analysis
SPR experiments were performed on a Biacore 3000 (GE
Healthcare). Flow channel 2 on a SA chip was loaded with roughly
500 RU biotinylated heparin (Sigma, 5 mg/ml) with a 1 min
injection at a ﬂow rate of 5 ml/min. Flow channels 1 and 2 were
then capped with a 1 min injection of biotin (10 mM) at 5 ml/min.
Kinetic studies of BMP2 binding to heparin was done with 2 fold
dilutions from 75 to 0 nM over 10 samples, 50 ml protein was
injected followed by 4 min of dissociation, with and without a
30 ml injection of 15 mM Surfen. All kinetics were done at 25 1C in
PBSþ0.1% BSA at a ﬂow rate of 50 ml/min. Binding data was
analyzed using the BIAevaluation software and ﬁtted to a 1:1
Langmuir model.
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Heparin-agarose beads (Sigma) were added to individual wells
of a 96-well plate. Non-speciﬁc binding was blocked overnight atFig. 1. Conditional deletion of Ext1 causes ectopic cartilage formation in long bones. (A
that reporter activity is present in inner perichondrial layer (arrows) in addition to its e
plate are both negative. The asterisk points to the prospective position of the groove o
(WT) long bone sections showing that inner and outer perichondrial layers contain typic
O-mildly positive round cells are present at the border (E, double arrowhead) likely
mutant limbs displaying ectopic cartilage formation. At E16, the ectopic Safranin O-pos
more conspicuous by P0 (I, J, arrowheads) and is surrounded by round perichondrial c4 1C with 0.1% BSA in 1PBS. 0–20 mM Surfen was added to
wells in triplicate and allowed to bind for 1 h. rhBMP was added
at the indicated concentrations and incubated for 1 h. Samples of
supernatant were harvested in SDS-PAGE sample buffer andand F) Histochemical staining of E16.5 Gdf5-Cre;R26R-LacZ limb sections showing
xpected presence in developing joints. Underlying epiphyseal cartilage and growth
f Ranvier. (B–E) Safranin O/Fast green-stained sections of E16.5 and P0 wild type
al cuboidal (arrowheads) and elongated cells (arrows), respectively. A few Safranin
representing newly-apposed chondrocytes. (G–J) Sections from Gdf5-Cre; Ext1ﬂ/ﬂ
itive tissue is small and close to native cartilage (G, H, arrowheads), but becomes
ells (J, arrows). Scale bars, 500 mm in A, 250 mm in B, 100 mm in C and F.
J. Huegel et al. / Developmental Biology 377 (2013) 100–112104electrophoresed on 12% Bis-Tris gels. Gels were stained with
silver nitrate according to the manufacturer’s instructions
(Biorad) and quantiﬁed by computer-assisted image analysis.Fig. 2. Gene expression is altered along mutant chondro-perichondrial border
in vivo. (A–G) WT long bone sections at E16.5 and PO (A and D) displaying typical
expression patterns of the cartilage markers collagen IIB (B,E) and Sox9 (F) and the
perichondrial marker tenascin-C (C). Proliferative H4C-positive cells are present in
both perichondrium and cartilage (G). (H–N) Sections from Gdf5-Cre; Ext1ﬂ/ﬂ
mutant limbs (H and K) show that the ectopic cartilage within perichondrium
expresses collagen IIB (I and L) and Sox9 (M) but not tenascin-C (J) and contains,
and is surrounded by, H4C-positive cells (N). Arrowheads indicate the location of
ectopic cartilage. Scale bar, 100 mm.Results
Ectopic cartilage forms in Ext1-deﬁcient mouse embryo long bones
In a recent study, we crossed Ext1ﬂox/ﬂox and Gdf5Cre mice to
conditionally ablate Ext1 expression in the mesenchymal interzone
cells that separate contiguous cartilaginous long bone anlagen in
mouse embryo limbs, resulting in a major drop in local HS levels
(Mundy et al., 2011). We found that the interzone’s function was
markedly disrupted and that the adjacent anlagen often fused
together, suggesting that the interzone’s ability to serve as a border
and boundary had been compromised or even lost. Interestingly, we
noted in companion Gdf5-Cre;R26R-LacZ embryos that Cre was
expressed not only in interzone cells as expected (Koyama et al.,
2008; Rountree et al., 2004), but also in inner layer perichondrial
cells present in the epiphyseal region of the anlagen (Fig. 1A and F,
arrows), a region anatomically encompassing the developing groove
of Ranvier (Fig. 1A and F, asterisk) (Burkus and Ogden, 1984). Thus,
we created additional Gdf5Cre; Ext1ﬂox/ﬂox mice to determine
whether and how Ext1 deﬁciency would affect the phenotype and
function of perichondrial cells in that region over developmental
time. In control E16.5 embryos and P0 neonates (Gdf5 or Gdf5Cre;
Ext1ﬂox/þ), the perichondrial cells had morphological characteristics
typical for those stages and the border between the cells and the
adjacent Safranin O-positive epiphyseal and growth plate cartilage
was obvious, continuous, smooth and well deﬁned (Fig. 1B and D).
The cells in the inner perichondrial layer were looser in density and
cuboidal-round in shape (Fig. 1C and E, arrowhead), while those in
the outer layer were denser and elongated (Fig. 1C and E, arrow).
Occasionally, a few Safranin O-slightly positive cells were seen along
the otherwise smooth border (Fig. 1E, double arrowhead), likely
representing newly-apposed and newly-differentiated chondrocytes
involved in normal appositional growth and lateral expansion of the
epiphysis (Burkus and Ogden, 1984; Solomon, 1966). In E16.5 Ext1-
deﬁcient embryos (Gdf5Cre; Ext1ﬂox/ﬂox), however, the chondro-
perichondrial border appeared to be compromised and uneven
and had become clearly so by P0 (Fig. 1G and I). In particular,
ectopic Safranin-O-positive cartilaginous tissue masses had formed
within it, were close to the cartilaginous anlagen at early stages, and
had grown larger and further outwards by P0 (Fig. 1H and J,
arrowheads). Penetrance of this phenotype was 100% (11/11).
Notably, most of the now numerous cells surrounding the cartila-
ginous outgrowth at P0 were round in shape (Fig. 1J, arrows),
hinting to the possibility that there had been an expansion of inner
layer progenitor cells around the ectopic cartilage.
In situ hybridization conﬁrmed that the ectopic tissue was in
fact cartilaginous and expressed such typical cartilage master and
matrix genes as Sox9 and collagen type IIB (Fig. 2H, I, K, L, and M,
arrowheads), while these genes were restricted to the cartilagi-
nous anlage and were undetectable in perichondrium in wild
types (Fig. 2A, B, D, E, and F). Expression analysis of histone 4C, a
marker of proliferating cells, showed that the ectopic chondro-
cytes and surrounding cells were all actively proliferating, thus
possibly contributing to overall tissue expansion and outgrowth
(Fig. 2N). Interestingly, analysis of tenascin-C expression (Fig. 2C),
a marker of articular tissue and epiphyseal perichondrium
(Koyama et al., 1995), showed that the ectopic cartilage was
largely negative as was the adjacent epiphyseal and growth plate
cartilage (Fig. 2J, arrowheads), indicating that the ectopic cartilage
resembled phenotypically transient growth plate cartilage rather
than permanent articular cartilage. To further analyze the nature
Fig. 3. Induction and location of ectopic cartilage vary along perichondrium. (A–F)
Sections of P0 Ext1ﬂox/ﬂox limb explants incubated with adenovirus encoding
Cre recombinase (Ad-Cre) for 5 days and exhibiting ectopic Safranin O-positive
tissue within perichondrium (B and D) but is absent in companion control
adeno-GFP (Ad-GFP) specimens (A and C). Incidence of ectopic cartilage formation
is much higher in epiphyseal than diaphyseal regions (E), but this does not
appear to reﬂect differential distribution of virus that was fairly uniform (F). (G-J)
Sections of P0 Ext1ﬂox/ﬂox limb explants treated with Surfen for 4 days and
showing ectopic cartilage (H and J) that, however, was absent in vehicle-treated
controls (G and I). Note that in all controls (A, C, G, and I), the chondro-
perichondrial border is intact and continuous. Scale bars, 250 mm in A, 75 mm in
C, and 500 mm in F.
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eYFP mice in which the Ext1-deﬁcient cells would also be eYFP-
positive. As to be expected, there was strong reporter signal within
the joints and ﬂanking perichondrial region, but also within the
ectopic tissue (Fig. S1, arrowheads). Expression did not characterize
every cell present, suggesting that the ectopic tissue consisted of
mutant and non-mutant cells. Growth plate cartilage was YFP-
negative (Fig. S1).
Perichondrium surrounds the cartilaginous anlagen along their
entire periphery, but the approach above using Gdf5-Cre mice
allowed us to examine only the portion ﬂanking the epiphysis.
Thus, to determine whether other perichondrial portions were
susceptible to ectopic cartilage formation, we isolated limbs from
P1 Ext1ﬂox/ﬂox neonates, removed the ectodermal tissue layer and
reared the resulting explants in organ culture in medium contain-
ing control GFP-encoding adenovirus (Ad-GFP) or Cre-encoding
adenovirus (Ad-Cre). Cultures were monitored over time and
processed for histochemical analysis of cartilage formation and
location over time. These experiments showed that ectopic
cartilage had in fact formed by 3–5 days of incubation in the
majority of the Ad-Cre-treated explants (13 out of 20 in three
independent experiments) (Fig. 3B and D), while no cartilage had
formed in companion explants receiving adeno-GFP and their
entire border was intact and their perichondrium was wholly
ﬁbrogenic (Fig. 3A and C). Most interestingly, when we compared
the frequency of ectopic cartilage formation with respect to the
long bone longitudinal axis, it was clear that the incidence was
higher in the epiphyseal than diaphyseal region by a ratio of
about 4 to 1 (Fig. 3E, po0.01). Such differential incidence did not
appear to reﬂect a differential distribution/action of adenovirus
given that companion specimens incubated with adeno-GFP
exhibited strong signal all along their surface (Fig. 3F). Similar
results were obtained when wild type P1 explants were exposed
to medium containing the HS antagonist Surfen (Schuksz et al.,
2008). Ectopic cartilage had clearly formed in the epiphyseal
region of Surfen-treated explants (5/7) but less frequently in the
diaphyseal region (Fig. 3H and J); companion explants treated
with vehicle showed no ectopic cartilage (Fig. 3G and I).
HS mediates the interaction of chondrogenic factors with target
cells, but is also critical to limit their availability, distribution and
action (Bernﬁeld et al., 1992; Lin, 2004). Thus, we asked whether the
formation of ectopic cartilage in Ext1-deﬁcient long bones was
preceded by, and possibly due to, ectopic activation of pro-
chondrogenic pathways. For proof-of-principle, we chose BMP
signaling since it has strong pro-chondrogenic activity (Weston
et al., 2000). Longitudinal sections of long bone anlagen from
E15.5 control and Gdf5Cre; Ext1ﬂox/ﬂox embryos were processed for
immunostaining with Smad1/5/8 antibodies. Indeed, in Ext1-deﬁ-
cient specimens, the perichondrial cells displayed clear and positive
nuclear staining (85.876.6%, n¼3) (Fig. 4B and D), while most
perichondrial cells in controls were negative (17.3710.9%, n¼4)
(Fig. 4A and C). A similar ectopic activation of BMP signaling was
observed in the perichondrium of Ext1ﬂox/ﬂox long bone explants
exposed to adeno-Cre (78.675.5%, n¼5) (Fig. 4F and H) but not in
those exposed to control adeno-GFP (23.374.5%, n¼3) (Fig. 4E and
G). Student’s t-test showed that these changes were statistically
signiﬁcant in mutant (p¼6106) and adeno-Cre treated samples
(p¼2104) as compared to controls.
Interference with Ext1 expression and HS function stimulates
chondrogenesis in vitro
The in vivo data above indicate that Ext1 deﬁciency stimulates
cartilage formation. To verify this notion and gain additional
insights on mechanisms, we resorted to high density micromass
cultures of early limb bud mesenchymal cells (Ahrens et al.,
Fig. 4. Ectopic BMP signaling in perichondrium. (A–D) Serial sections of E15.5 WT
and Gdf5-Cre; Ext1ﬂ/ﬂ radii processed for Safranin-O staining (A and B) or pSmad1/
5/8 immunostaining (C and D). Note the strong ectopic immunostaining in the
nuclei of perichondrial cells in mutant (D) but only weaker staining in WT (C). The
proliferative zone of growth plate in all specimens exhibits positive staining that
acted as an internal positive control. (E and H) Nuclear immunostaining is also
prevalent in perichondrium of P1 Ext1ﬂox/ﬂox explants exposed to adeno-Cre (F and
H), while very few cells are positive in control explants treated with adeno-GFP (E
and G). Scale bars, 250 mm in A, 100 mm in C.
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like multilayer and, over time, give rise to cartilaginous nodules
each round in shape and fully separated from neighboring
nodules by ﬁbroblastic and muscle cells (Paciﬁci et al., 1980).
Thus, we isolated limb bud mesenchymal cells from E11.5 wild
type and Ext1ﬂox/ﬂox mouse embryos and seeded them in micro-
mass culture overnight. To interfere with Ext1 expression and HS
function, the Ext1ﬂox/ﬂox cultures were exposed to adeno-Cre
(or adeno-GFP as control), whereas the wild type cultures were
treated with different doses of Surfen or heparitinase I added
daily to the medium (or vehicle as control). Chondrogenesis and
nodule formation were monitored over the following 6–8 days by
microscopic inspection and histochemical staining. As to be
expected, all control cultures displayed a sizable number of Alcian
blue-positive nodules by day 5 or 6 (Fig. 5A, B, and C, left panels),
but the number and size of the nodules were clearly higher in allthe treated cultures (Fig. 5A, B, and C, right panels). Imaging
analysis showed that the number of nodules was nearly doubled
by treatment with 10 mM Surfen (Fig. 5E), while both the total
cartilage area and average nodule size were increased in adeno-
Cre cultures (Fig. 5F) (n¼5, po0.01). An excess number of
nodules was also described in heparitinase-treated chick micro-
mass cultures in a previous study (Fisher et al., 2006). Of much
interest was the ﬁnding that while the majority of nodules in
control cultures were well deﬁned, round, evenly dispersed and
fully distinct from neighboring nodules (Fig. 5D, left panel), many
of the nodules present in treated cultures were ill shaped and had
fused into large amorphous cartilaginous masses (Fig. 5D, right
panel). Furthermore, quantitative PCR revealed increases in tran-
script levels of several key chondrogenic gene regulators, includ-
ing Sox9 and Runx2, in a dose-dependent manner (Fig. 5G).
Transcripts encoding the cartilage matrix constituents aggrecan,
collagen type IIB and collagen type X were also upregulated.
To determine whether the increased chondrogenesis in treated
cultures was associated with, and likely caused by, changes in
BMP signaling, similar E11.5 mouse embryo limb bud micromass
cultures were treated with Surfen in absence or presence of the
BMP inhibitor Noggin. While Surfen treatment had led to excess
Alcian blue-positive nodule formation (Fig. 6C), this response was
fully counteracted by Noggin co-treatment (Fig. 6D). In good
correlation, the increased chondrogenesis induced by Surfen
was further enhanced by co-treatment with rhBMP2 (Fig. 6E
and H). To determine whether BMP signaling was activated early
during the chondrogenic response, freshly-isolated limb bud cells
were transfected with the BMP reporter plasmid Id1-Luc
(Korchynsky and ten Dijke, 2002), seeded in micromass culture,
and treated with: vehicle; Surfen; rhBMP2; Surfen plus BMP2;
Noggin; or Surfen plus Noggin. Twenty-four hours later, whole
cell homogenates were processed for luciferase assays normalized
with renilla luciferase. When given singly, Surfen (10 mM) or
rhBMP2 (0.1 mg/ml) stimulated reporter activity about 3-fold
above controls (Fig. 6I). Co-treatment with Surfen plus rhBMP2
had strong additive effects and boosted reporter activity by over
14 fold (Fig. 6I). Noggin treatment by itself reduced basal
endogenous Id1-Luc activity and reduced the stimulation by
Surfen (Fig. 6I). Potency of BMP antagonism by Noggin has been
shown to be comparable in the absence of HS-binding (Paine-
Saunders et al., 2002).
Whole cell homogenates from the above cultures were pro-
cessed for immunoblot analysis of pSmad1/5/8 and total Smad1
levels. Clearly, Surfen and rhBMP2 greatly increased pSmad1/5/8
levels as early as 4 h of treatment and, interestingly, the increases
persisted at least until 24 h, while overall Smad1 levels did not
change signiﬁcantly (Fig. 6J). Such persistent signaling likely
reﬂected the high density tissue-like (and thus more physiologic)
organization of the micromass cultures, given that when tested in
cells in monolayer (a more artiﬁcial condition), BMP signaling
usually peaks at 2 h and then decreases (Kuo et al., 2010). RT-PCR
analysis with companion samples showed that endogenous BMP2
gene expression was increased as well by treatment with Surfen
or rhBMP2 over control values (po0.05) as was expression of
both BMPR-I and BMPR-II, possibly contributing to signal ampli-
ﬁcation and persistence (Fig. 6K and M).
Modulation of BMP2/HS interactions by Surfen
The enhanced chondrogenesis and ectopic cartilage formation
seen after interference with HS function (as well as the early
stimulation of BMP reporter activity and Smad1/5/8 phosphoryla-
tion) may reﬂect increased levels of ‘‘free’’ BMP protein able to
interact with its receptors and elicit biologic responses (Umulis
et al., 2009). The binding kinetics of the BMP/HS interaction and the
Fig. 5. HS antagonism stimulates chondrogenesis in vitro. (A–D) Representative micromass cultures of E11.5 mouse embryo limb mesenchymal cells showing that
formation of Alcian blue-positive cartilage nodules is stimulated by treatment with heparitinase I (A), adeno-Cre (B) or Surfen (C and D) for 6 days compared to respective
vehicle-treated controls. Note that, interestingly, nodules are round and distinct in controls (D, left panel), while they are fused into large amorphous masses in Surfen-
treated cultures (D, right panel). (E and F) Histograms showing that nodule number increases in a dose-dependent manner in Surfen-treated cultures (E); similarly, total
nodule area and average size are higher in adeno-Cre-infected than control adeno-GFP cultures (F). Values are meansþS.E. of ﬁve wells. (G) Quantitative PCR analysis
showing that expression of chondrogenic genes increases proportionally to Surfen dose, in line with the dose-dependent increases in nodule number (E). Values are
representative of three independent experiments. Scale bars, 3 mm in A, 300 mm in D. *, po0.05 compared to control.
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plasmon resonance. We coupled biotinylated heparin chains to
streptavidin-derivatized sensor chip and injected rhBMP2 over the
surface in concentrations ranging between 0.3 and 75 mM (Fig. 7A;
Table 1) (Bramono et al., 2012; Kuo et al., 2010). Pretreating the
heparin with Surfen (15 mM) drastically decreases the amount of
rhBMP2 that can bind to the surface (Fig. 7B). Association and
dissociation rates as well as constants for the rhBMP2/HS interaction
were calculated by ﬁtting the data to a 1 to 1 binding model. To
calculate the kinetic parameters for rhBMP2 binding to Surfen-
treated HS, it was assumed that the association rate of the rhBMP2
to the available HS was the same as for the wild-type interaction.
The data shows that pre-treating heparin with Surfen reduces
rhBMP2 binding (Fig. 7B) and that the rhBMP2 bound to Surfen
treated heparin dissociates faster (Table 1).
To verify the dynamicism of BMP/HS interactions, we used a
solid phase assay with heparin-coupled agarose beads. Increasing
amounts of beads were ﬁrst incubated with a ﬁxed amount ofrhBMP2 (100 ng) for 1 h; beads were then centrifuged to separate
bound and unbound (‘‘free’’) protein and the latter was resolved
by gel electrophoresis. Optical measurements after silver staining
showed that the amount of unbound rhBMP2 decreased linearly
with increasing amounts of heparin beads as expected (Fig. 7C
and D). Control experiments indicated that BMP2 has no afﬁnity
for unconjugated agarose beads (Fig. S2). We selected the bead
amount producing the lowest levels of unbound rhBMP2 (50 mg),
and carried out additional binding assays using such amount of
beads and a ﬁxed amount of rhBMP2 (100 ng). Beads and protein
were incubated for 1 h after which increasing concentrations of
Surfen were added. One hour later, beads were centrifuged and
the unbound protein was resolved and quantiﬁed by electrophor-
esis as above. Clearly, Surfen was able to displace rhBMP2 from
the heparin beads and increased the levels of unbound protein by
2–3 fold in a dose-dependent manner (Fig. 7E and F). The levels of
unbound protein were proportional to biological activity as
indicated by reporter assays (not shown).
Fig. 6. HS antagonism modulates chondrogenic response to BMP2. (A–H) Representative mouse limb bud cell micromass cultures stained with Alcian blue on day
6 showing that cartilage nodule formation is stimulated by Surfen (C) or rhBMP2 (F) over respective controls (A and E). The pro-chondrogenic effects of Surfen are
prevented by Noggin co-treatment (D), but are further enhanced by rhBMP2 co-treatment (H). (I) Id1-luc reporter assays indicating that treatment with either rhBMP2 or
Surfen increases BMP signaling while rhBMP2/Surfen co-treatment stimulates it over 10-fold; Noggin treatment reduces it. Values are meansþS.E. of three experiments. (J)
Immunoblots showing that the levels of phosphorylated Smad1/5/8 are increased by treatment with rhBMP2 or Surfen by 4 h and remain high, while total Smad1 levels
remain steady. (K–M) RT-PCR analysis showing that BMP2, BMPRI and BMPRII expression increases over time after initiating rhBMP2 or Surfen treatment. Values are
means7S.E. of three experiments. Scale bar, 3 mm in A.
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The results of the study provide evidence that perichondrium
does in fact rely on Ext1 expression and HS to acquire and maintain
its phenotype, organization and roles. When such endogenous
mechanisms are experimentally altered, the chondro-perichondrial
border becomes uneven and ectopic cartilage forms and grows
within it. Overt formation of ectopic cartilage is ﬁrst appreciable
around E16.5 which corresponds to approximately 3 days from
when Gdf5-Cre expression becomes detectable in the developing
epiphyseal areas (Koyama et al., 2008). Similarly, ectopic cartilage
ﬁrst becomes visible within 3–4 days from when the long bone
explants were exposed to adeno-Cre, heparitinase or Surfen. Inter-
estingly, however, ectopic BMP signaling within perichondrium is
appreciable sooner and precedes overt cartilage formation. These data
signify that perichondriummust possess a number of mechanisms to
maintain the phenotype of its cells and resist their phenotypicreprogramming. It may also be that the tissue possesses an adequate
reservoir of HS at the moment of experimental intervention that
needs to undergo turnover and/or structural and functional destabi-
lization before pro-chondrogenic pathways and mechanisms can take
over and initiate ectopic cartilage formation. Whatever the explana-
tion, what is interesting is that ectopic cartilage eventually forms and
not other tissues, implying that the lineage options for the cells
residing along the border are not open-ended but rather limited and
seemingly pre-speciﬁed.
Our ﬁnding that the incidence of ectopic cartilage formation is
higher in the epiphysis than diaphysis has important implications
given that epiphysis and diaphysis undergo markedly different
developmental processes during development. The major process
occurring in the early diaphysis is the formation of the primary
ossiﬁcation center consequent to cartilage hypertrophy and blood
vessel invasion (Kronenberg, 2003). In comparison, the epiphysis
is a more complex and dynamic structure in which the joints form
Fig. 7. Binding interactions between BMP2 and heparin are reversed by HS
antagonism. (A) Association–dissociation curves of rhBMP2 injected on a strepta-
vidin chip coated with biotinylated heparin. Binding constants were calculated
and are shown in Table 1. (B) Binding of rhBMP2 is substantially decreased when
the heparin is pre-treated with Surfen (red lines). (C and D) Solid phase assays
(bottom histograms) and gel electrophoresis analysis (top gel bands) showing that
the fraction of unbound rhBMP2 decreases with increasing amounts of heparin-
coated beads (C), while this trend is reversed in the presence of increasing doses of
Surfen (D). Values are means7S.E. of four wells.
Table 1
Rate and equilibrium constants for rhBMP2/heparin binding.
Vehicle Surfen
kon (M
1s1) 1.8 (70.4)103 1.8 (70.4)103
koff (s
1) 8.6 (70.9)104 4.6 (70.8)103
Ka (M
1) 2.0 (70.1)106 3.9 (70.8)105
Kd (M) 4.9 (70.2)107 2.6 (70.5)106
Rate constants (koff and kon) and association (Ka) and dissociation (Kd) constants
for rhBMP2 binding to heparin, in absence and presence of Surfen, as measured by
surface plasmon resonance. Constants are a mean of three separate experiments.
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growth plate is present and sustains longitudinal growth, and a
secondary ossiﬁcation center will eventually form. As importantly,the epiphysis needs to enlarge and expand laterally by apposi-
tional growth and achieve a much larger diameter compared to
the diaphysis (Burkus and Ogden, 1984; Porter and Simpson,
1999; Solomon, 1966); such expansion is needed to accommodate
the joints and other tissues and sustain the overall epiphysis
mechanically. Indeed, we do often observe the presence of
chondrocytes intimately associated to the surface of the control
cartilaginous anlagen that likely represent newly-apposed and
newly-differentiated cells originating from perichondrial inner
layer (see Fig. 1E). Thus, it is conceivable and possible that the
ectopic cartilage formation occurring in Ext1-deﬁcient long bone
anlagen in vivo or explant culture is an ampliﬁcation of that
natural process propelled by ectopic pro-chondrogenic signaling
activity, increased availability of ‘‘free’’ chondrogenic factors, and
precocious recruitment of progenitor cells into the chondrogenic
lineage. The pro-chondrogenic pathways involved could include
BMP signaling as our data suggest, but also others. For example,
we showed previously that hedgehog proteins greatly stimulate
chondrogenesis (Enomoto-Iwamoto et al., 2000) and that a re-
distribution of Ihh from growth plate to perichondrium leads to
ectopic cartilage formation (Koyama et al., 2007).
Recruitment of progenitor cells from perichondrium and/or
the groove of Ranvier was previously invoked to explain the
origin of exostosis-forming cells in children with HME and to
account for the fact that the exostoses form next to, but never
within, the growth plate itself (Hecht et al., 2005; Porter and
Simpson, 1999). A possible role of cells from the groove of Ranvier
is particularly attractive since the groove does contain both fast-
and slow-proliferating progenitor cells, the latter typical of a stem
cell niche (Karlsson et al., 2009). Studies we and others have
conducted in mouse models of HME have indicated that condi-
tional ablation of Ext1 in growth plate chondrocytes – using Col2-
Cre or Col-CreERmice – also leads to formation of ectopic cartilage
around the epiphyses (Jones et al., 2010; Matsumoto et al., 2010a;
Zak et al., 2011). These and other studies (Clement et al., 2008)
have raised the alternative possibility that the exostoses are
actually produced by growth plate chondrocytes themselves and
in particular by chondrocytes located on the periphery of the
growth plate abutting the chondro-perichondrial border. As in the
case of progenitor cells above, the mutant growth plate chondro-
cytes would overgrow into and within perichondrium and act as
benign cartilage tumor cells because they are deﬁcient in Ext
expression and HS production. Indeed, when they were initially
studied, Ext genes were deﬁned as tumor suppressors, a deﬁnition
they still have (McCormick et al., 1998). It is interesting to note
also that ectopic cartilage in the mouse models and exostosis
cartilage from HME patients appear to contain a mixed popula-
tion of both mutant and wild type cells, suggesting that the
mutant cells may ‘‘recruit’’ normal cells to spur further ectopic
growth and that relatively few mutant cells are sufﬁcient for
exostosis formation (de Andrea et al., 2012; Jones et al., 2010;
Matsumoto et al., 2010a). This concept is also supported by our data
demonstrating a combination of both YFP-positive and negative cells
(representing Ext1-deﬁcient andWT cells, respectively) within ectopic
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propose here a model that aims to reconcile previous data and
disparate conclusions regarding the origin of exostosis-forming cells
(model in Fig. 8). It is possible that the initial cells triggering the onset
of ectopic cartilage formation in mice (or exostoses in patients) could
be growth plate or perichondrial in origin. Once this process initiates,
it would self-propel because: the mutant cells have higher respon-
siveness to growth factors such as BMPs and higher chondrogenic
capacity; the growth factors themselves would be more broadly
distributed and freer to interact and act; and the mutant cells would
recruit wild type (perichondrial or growth plate) cells to further
propel the overgrowth process.
The data from the limb mesenchymal cells in micromass
cultures sustain these possibilities and provide additional mechan-
istic clues. The levels of Id1-luc reporter activity, pSmad1/5/8 and
BMP2/BMPR expression all increase rapidly within 4–8 h of HS
interference but are sustained for at least 24 h, and the timing and
degrees of these responses are similar to those elicited by treatment
with exogenous rhBMP2. We show also by surface plasmon reso-
nance and solid phase assays that the HS/rhBMP2 physical associa-
tion is highly dynamic and can be reversed or even prevented. The
data suggest that the overall HS-dependent regulatory mechanisms
are dynamic as well and can be quickly altered to increase (and
maintain) responsiveness to BMPs and possibly other factors. Due toFig. 8. Model of ectopic cartilage/exostosis formation. (A) In WT developing long
bones, perichondrium (in red) and cartilage (in blue) acquire and maintain their
distinct phenotypes and would interact in a variety of ways to sustain skeletal
growth and morphogenesis. Normal phenotypic traits of perichondrium would
include Ext/HS expression, low protein signaling (such as BMP signaling) and low
chondrogenic activity. (B) In conditional Ext mutants (or following treatment with
Surfen or heparitinase I), perichondrium would lose its normal phenotypic
properties and become depleted of Ext/HS, but would exhibit higher signaling
protein and chondrogenic activities. These changes would induce progenitor cells,
including those from the groove of Ranvier (GR), to undergo chondrogenesis and
form local ectopic cartilage/exostosis (red round cells). The outgrowth process
could be aided by recruitment of wild type growth plate cells and also by
increased diffusion of BMPs, hedgehogs and growth plate-derived factors (yellow
arrow) as we suggested previously (Koyama et al., 2007). Similar overall mechan-
isms could operate when conditional Ext ablation is directed to growth plate
chondrocytes as seen in recent studies (see text). Exostosis formation in HME
patients could follow a similar pathogenic cascade or may be more complex given
that their EXT mutations are systemic.elevated ligand and receptor expression as well as physical associa-
tion of the two, such increased and long-lasting responsiveness
could be instrumental to prolong active signaling. In turn, this could
lead to the increases in chondrogenesis and cartilage nodule forma-
tion occurring over time in these cultures (or ectopic cartilage
formation in vivo and explant culture). Why then do the nodules
fuse and what does this phenomenon mean? It is possible that the
fusion of the nodules is merely due to the fact that they had
increased in size and number and there was insufﬁcient space left
for them to remain individually. An alternative and more likely
possibility is that the treated or mutant nodules had lost their innate
boundary control mechanisms, fusing into large but amorphous and
irregular cartilaginous masses. In fact, it was previously shown that
each nodule is normally surrounded by a multilayered tissue that
closely resembles perichondrium in cell arrangement and conﬁg-
uration and gene expression patterns (Solursh et al., 1982), and we
recently showed that there was extensive intermingling of pSmad1/
5/8-positive chondrocytes and ﬁbronectin-positive perichondrial-
like cells within/around the nodules in micromass cultures prepared
with mutant Prx1Cre; Ext1ﬂox/ﬂox mouse embryo limb bud cells
(Matsumoto et al., 2010b).
In addition to chondro-perichondrial cell intermingling, we
observed an overall decrease in nodule formation in the Prx1Cre;
Ext1ﬂox/ﬂox micromass cultures rather than an increase we observe
here following treatment of Ext1ﬂox/ﬂox micromass cultures with
adeno-Cre, heparitinase or Surfen. Similarly, the mutant Prx1Cre;
Ext1ﬂox/ﬂox limbs displayed growth retardation and signiﬁcant
decreases in chondrogenesis and cartilage development rather
than a stimulation of ectopic cartilage formation we observe in
our Gdf5Cre; Ext1ﬂox/ﬂox embryos. There are several explanations
and interesting implications for these seemingly contradictory
observations. One possibility is that because Prx1Cre targets the
entire limb mesenchyme from very early stages, the resulting
generalized deﬁciency in Ext1 could have hampered overall cell
survival and proliferation, leading to a hypomorphic cartilage
phenotype in vivo and reduced nodule formation in vitro. Mouse
embryogenesis is in fact halted around E8.5 when both Ext1
alleles are deleted (Lin et al., 2000). In the present study, we
used adenovirus infection or enzymatic or small molecule treat-
ment to reduce (but not eliminate) Ext1 expression or HS levels/
function in cultured cells possibly accounting for the stimulation
of chondrogenesis we observe. A second possibility is that Ext1
may have different roles at different stages of chondrogenic cell
commitment and differentiation and/or different skeletal sites
and contexts, thus eliciting different phenotypic outcomes if it is
deleted early versus late or broadly versus locally (Bishop et al.,
2007; Lin, 2004). While more work is needed to sort out these and
other possibilities, our data do indicate that Ext deﬁciency and HS
interference render the perichondrium unable to maintain its
phenotype and remain close to, but distinct from, growth plate
cartilage. Further understanding of these mechanisms should
illuminate the intricacies of this essential tissue–tissue interac-
tion and should also pave the way toward effective therapies for
HME and related conditions.Acknowledgments
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